T80.51XA Anaphylactic reaction due to administration of blood and blood products, initial encounter

Name of the Condition

• Anaphylactic reaction due to administration of blood and blood products, initial encounter.

Summary

This condition describes an acute, severe allergic reaction occurring after the administration of blood or blood products, marked by rapid onset and potentially life-threatening symptoms. It is a hypersensitivity response involving multiple organ systems, requiring immediate medical intervention.

Causes

Anaphylactic reactions to blood and blood products typically result from immune-mediated responses to components in the transfused material, such as plasma proteins, white blood cells, or platelets. Rarely, reactions may be triggered by contaminants or additives in the blood product.

Risk Factors

• Prior history of allergic reactions to blood products
• Presence of specific antibodies (e.g., anti-IgA in IgA-deficient patients)
• Repeated transfusions increasing sensitization risk
• Underlying allergic or autoimmune conditions
• Use of blood products with high plasma content

Symptoms

• Sudden onset of hives, itching, or widespread rash
• Swelling of the lips, tongue, or throat
• Difficulty breathing or wheezing
• Rapid heartbeat, dizziness, or fainting
• Nausea, vomiting, or abdominal cramps
• Drop in blood pressure (hypotension)

Diagnosis

Diagnosis is based on clinical presentation, timing relative to blood product administration, and exclusion of other causes. Key indicators include rapid symptom onset, multisystem involvement, and response to epinephrine. Laboratory tests may assess for elevated tryptase or specific antibodies, though these are often confirmatory rather than diagnostic.

Treatment Options

Immediate treatment focuses on epinephrine administration, airway support, and intravenous fluids. Antihistamines and corticosteroids may be used adjunctively. Discontinuation of the transfusion is critical, and monitoring for biphasic reactions is necessary.

Prognosis and Follow-Up

With prompt treatment, most patients recover fully. However, severe cases may require intensive care. Follow-up includes monitoring for delayed reactions and evaluation for future transfusion safety, such as pre-transfusion testing or specialized blood product selection.

Complications

• Respiratory failure requiring mechanical ventilation
• Cardiovascular collapse or shock
• Laryngeal edema leading to airway obstruction
• Multi-organ dysfunction in severe cases

Lifestyle & Prevention

• Pre-transfusion screening for known allergies or antibodies
• Use of leukoreduced or washed blood products when indicated
• Slow infusion rates for high-risk patients
• Immediate availability of emergency medications during transfusion

When to Seek Professional Help

Seek urgent medical attention if symptoms of anaphylaxis occur during or after a blood transfusion, including difficulty breathing, swelling, or dizziness. Do not wait for symptoms to worsen.

Tips for Medical Coders

Document the timing of symptom onset relative to the transfusion, specific blood product administered, and clinical interventions. Ensure "initial encounter" is coded only for the first episode of this reaction type. Note any pre-existing sensitivities or prior reactions to support coding accuracy.